Janux Therapeutics
JANX
#6214
Rank
A$1.44 B
Marketcap
A$23.70
Share price
-2.34%
Change (1 day)
-43.36%
Change (1 year)

Earnings for Janux Therapeutics (JANX)

Earnings in 2026 (TTM): -A$0.16 Billion

According to Janux Therapeutics's latest financial reports the company's current earnings are A$24 Million. In 2025 the company made an earning of -A$0.17 Billion a decrease over its 2024 earnings that were of -A$98.14 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Janux Therapeutics from 2020 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.16 Billion-6.29%
2025 -A$0.17 Billion64.69%
2024 -A$98.14 Million18.36%
2023 -A$82.92 Million-7.56%
2022 -A$89.7 Million93.01%
2021 -A$46.48 Million381.6%
2020 -A$9.65 Million